Le Lézard
Classified in: Ebola virus, Health
Subject: SVY

Brazil Nephrology and Urology Devices Market Outlook to 2023 - Incontinence Devices, Lithotripters and Renal Dialysis Equipment


LONDON, Aug. 28, 2017 /PRNewswire/ -- Brazil Nephrology and Urology Devices Market Outlook to 2023 - Incontinence Devices, Lithotripters and Renal Dialysis Equipment

Summary
GlobalData's new report, "Brazil Nephrology and Urology Market Outlook to 2023", provides key market data on the Brazil Nephrology and Urology market. The report provides value, in millions of US dollars and volume (in units) within market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

Download the full report: https://www.reportbuyer.com/product/5082230/

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
- Market size and company share data for Nephrology and Urology market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the Brazil Nephrology and Urology market.
- Key players covered include Kimberly-Clark Corporation, Baxter International Inc, Medtronic plc, Cardinal Health Inc, First Quality Enterprises Inc, Fresenius Medical Care AG & Co KGaA, Svenska Cellulosa Aktiebolaget, C. R. Bard Inc, Asahi Kasei Corp, Teleflex Inc, W. L. Gore & Associates Inc, Ontex Group N.V. and others

Reasons to buy
- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
Download the full report: https://www.reportbuyer.com/product/5082230/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....



News published on and distributed by: